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Abstract
Background: FGF signalling regulates numerous aspects of early embryo development. During gastrulation in
amniotes, epiblast cells undergo an epithelial to mesenchymal transition (EMT) in the primitive streak to form the
mesoderm and endoderm. In mice lacking FGFR1, epiblast cells in the primitive streak fail to downregulate E-
cadherin and undergo EMT, and cell migration is inhibited. This study investigated how FGF signalling regulates
cell movement and gene expression in the primitive streak of chicken embryos.
Results: We find that pharmacological inhibition of FGFR activity blocks migration of cells through the primitive
streak of chicken embryos without apparent alterations in the level or intracellular localization of E-cadherin. E-
cadherin protein is localized to the periphery of epiblast, primitive streak and some mesodermal cells. FGFR
inhibition leads to downregulation of a large number of regulatory genes in the preingression epiblast adjacent
to the primitive streak, the primitive streak and the newly formed mesoderm. This includes members of the FGF,
NOTCH, EPH, PDGF, and canonical and non-canonical WNT pathways, negative modulators of these pathways,
and a large number of transcriptional regulatory genes. SNAI2 expression in the primitive streak and mesoderm
is not altered by FGFR inhibition, but is downregulated only in the preingression epiblast region with no
significant effect on E-cadherin. Furthermore, over expression of SNAIL has no discernable effect on E-cadherin
protein levels or localization in epiblast, primitive streak or mesodermal cells. FGFR activity modulates distinct
downstream pathways including RAS/MAPK and PI3K/AKT. Pharmacological inhibition of MEK or AKT indicate
that these downstream effectors control discrete and overlapping groups of genes during gastrulation. FGFR
activity regulates components of several pathways known to be required for cell migration through the streak
or in the mesoderm, including RHOA, the non-canonical WNT pathway, PDGF signalling and the cell adhesion
protein N-cadherin.
Conclusions: In chicken embryos, FGF signalling regulates cell movement through the primitive streak by
mechanisms that appear to be independent of changes in E-cadherin expression or protein localization. The
positive and negative effects on large groups of genes by pharmacological inhibition of FGF signalling, including
major signalling pathways and transcription factor families, indicates that the FGF pathway is a focal point of
regulation during gastrulation in chicken.
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Vertebrate gastrulation is a highly coordinated process
that leads to formation of the three primary germ layers
(ectoderm, mesoderm and endoderm) and sets up the
body plan for subsequent organ development. The mor-
phogenetic aspects of gastrulation vary considerably
across different groups of organisms. In general, cells
in an outer embryo layer move inward to form the
mesoderm and the endoderm, while simultaneously
large-scale cell movements and changes in cell shape
transform overall embryo structure [1,2].
A defining feature of gastrulation in amniotes (reptiles,
birds and mammals) is that mesoderm cells arise from
the epithelial epiblast through an EMT in the primitive
streak [3,4]. This contrasts with mesoderm development
in lower vertebrates such as frogs and fish in which pre-
sumptive mesodermal cells involute and migrate as a
generally contiguous sheet. In chicken, the primitive
streak arises following dramatic polonaise cell move-
ments within the epiblast, leading to cell intercalation in
the preingression epiblast region [5-7].
Primitive streak formation and the emergence of endo-
derm and mesoderm is closely integrated with changes in
cell fate. Both processes are regulated by several growth
factor signalling pathways, including the canonical and
non-canonical WNT, PDGF, BMP, NODAL, and FGF
pathways [5,6,8-12]. In situ hybridization (ISH) analyses
have shown that members of multiple signalling path-
ways are expressed in the primitive streak regions of gas-
trula stage chicken embryos [13-20]. Some of these
pathways, as well as other mechanisms, regulate cell
migration in the primitive streak [16,18,21-23].
FGF signalling is an important mediator of mesoderm
induction and gastrulation movements. FGFs can induce
mesoderm in frog animal caps and avian epiblast [24-26].
Mouse embryos lacking FgfR1 initially form a streak, but
cells fail to undergo EMT due to the absence of Snai1
expression and failure to downregulate E-cadherin [27].
The downregulation of E-cadherin via transcriptional
repression by Snail proteins is considered a prerequisite
for EMT in many contexts [28,29], including during
mouse gastrulation [27].
In chicken embryos, FGFR1 signalling is necessary for
the primitive streak to form [6,30,31]. Following emer-
gence of mesoderm cells from the primitive streak, FGFs
appear to act as chemotactic factors that influence meso-
derm migration. Mesoderm cells will migrate towards a
source of FGF4 but away from FGF8 [21]. In mouse
embryos lacking Fgf8, emerging mesoderm cells gastrulate
but fail to migrate away from the primitive streak [32].
Together, these findings indicate that FGF signalling plays
a primary role in regulating primitive streak formation,
mesoderm induction, and mesoderm migration.
In this study, we investigate how FGF signalling and
its downstream effectors regulate cell movement and
gene expression in and around the primitive streak of
chicken embryos after the onset of gastrulation. In con-
trast to results of genetic ablation studies in mice [27],
pharmacological inhibition of FGFR activity blocks
migration of cells through the primitive streak of
chicken embryos by mechanisms that appear to be inde-
pendent of E-cadherin localization or expression levels.
E-cadherin protein levels are high throughout the epi-
blast, in cells undergoing EMT, and in the newly formed
mesoderm, and are unaffected by over expression of
SNAIL. FGFR inhibition leads to downregulation of a
large number of regulatory and effector genes through
both the RAS/MAPK and PI3K/AKT pathways.
Results
Regulatory gene expression in gastrula stage chicken
embryos
To obtain an overview of regulatory gene expression pat-
terns in the primitive streak, stage 4 embryos were assayed
by ISH for expression of a candidate group of transcrip-
tion factors, growth factors, and receptors. Analysis of
whole embryos and transverse embryo sections identified
several patterns that can be described by combinatorial
expression in one or more of the following morphological
domains: lateral epiblast, preingression epiblast, primitive
streak, medial mesoderm, and lateral mesoderm (Figure
1A). For example, FGFR1 is expressed in the lateral epi-
blast, the preingression epiblast, and the primitive streak,
but at greatly reduced levels in the newly formed meso-
derm (Figure 1B, B’). FGFR2 and FGFR3 transcripts are
detected in the lateral epiblast but at much lower levels in
the preingression epiblast and primitive streak (Figure 1C-
D, C’-D’). Genes such as EPHA1, FGF4, FGF8, PDGFRA,
and DLL1 are expressed in the preingression epiblast and
primitive streak, and then downregulated in the mesoderm
(Figure 1E-I, E’-I’; for this study, the preingression epiblast
is defined as the domain of epiblast adjacent to the primi-
tive streak that expresses these genes). SNAI2 shows a
similar expression pattern except that transcripts persist to
more lateral regions of the mesoderm (Figure 1J, J’). T,
WNT5B, WNT8A,a n dNOTCH1 are expressed in the pre-
ingression and more lateral epiblast, the primitive streak,
and the mesoderm extending to the lateral regions (Figure
1K-N, K’-N’). Finally, genes such as EFNB2 are expressed
in the primitive streak and broadly in the mesoderm
(Figure 1O, O’).
FGF signalling is required for cell migration through the
primitive streak
Several observations suggest that FGF signalling is
active in the preingression epiblast and primitive
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Page 2 of 17Figure 1 Domains of gene expression in the gastrula stage chicken embryo. A: Transverse section through the mid-streak region of a stage
4 embryo depicting domains represented by the expression patterns in B-O, B’-O’ (green, lateral epiblast; pink, preingression epiblast; lavender,
primitive streak; orange, medial mesoderm; purple, lateral mesoderm). B-O: Whole mount ISH localization of mRNAs coding for signalling
molecules, receptors and growth factors in stage 4 embryos. B’-O’: Transverse sections at the indicated levels through corresponding embryos in
B-O. Abbreviations: EPI, epiblast; MES, mesoderm.
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Page 3 of 17streak. First, FGF3, FGF4, FGF8, FGF13,a n dFGF19
are expressed in these domains (Figure 1F, G; [33]).
Second, FGFR1 transcripts are detected in the lateral
and preingression epiblast and in the primitive streak,
but at low or undetectable levels in the emerging
mesoderm (Figure 1B, B’; [17,20]). FGFR2 and FGFR3
are expressed at high levels in the lateral epiblast but
at much lower or undetectable levels in the preingres-
sion epiblast, primitive streak, and mesoderm (Figure
1C-D, C’-D’). FGFR4 transcripts are detected only in
extraembryonic regions [17,20]. Third, activated ERK
(dpERK), an indicator of FGF signalling, is detected in
the preingression epiblast and the primitive streak,
with much lower or undetectable levels in emerging
mesoderm [17]. While RNA localization may not
reflect protein expression, these results nevertheless
suggest that the FGFR1 receptor is present and active
in the primitive streak.
To determine if FGFR activity is required for cell
migration through the primitive streak, stage 3d-4
embryos were pretreated for two hours with the FGFR
inhibitor SU5402 [34,35] or with DMSO as a control,
and then electroporated with a GFP expression plas-
mid [36]. Extensive control experiments have shown
that this electroporation protocol specifically targets
cells in the epiblast [16], and so assaying for GFP-
positive cells in the mesoderm following a period of
development reflects the ability of cells to move from
the epiblast through the primitive streak. The concen-
tration of SU5402 used (100 μM) was determined by
preliminary titration studies to assess the minimum
concentration that would abolish detectable expression
of T (Brachyury) by ISH and phospho-ERK by western
blot.
Analysis of GFP-positive cells in control embryos
five hours following electroporation showed typical
migration patterns of cells through the primitive
streak (Figure 2A-A”). GFP-positive cells were distrib-
uted in the lateral and preingression epiblast, primitive
streak, and mesoderm layers. In contrast, GFP-positive
cells in SU5402-treated embryos were present in the
epiblast and primitive streak regions but were rarely
observed in the mesoderm layer (Figure 2B-B”). Cell
counts indicated that significantly more positive cells
were retained in the epiblast (lateral plus preingres-
sion regions; 78.5% versus 59.0% respectively; p <
0.001) and primitive streak (20.6% versus 13.4%; p <
0.001) in SU5402 versus DMSO treated embryos,
while contribution to the mesoderm was virtually
abolished by SU5402 (1.0% versus 27.6%; p < 0.001;
Figure 2C). This data indicates that FGFR activity
is required for cells to transition from the epiblast
through the primitive streak to populate the
mesoderm.
FGF receptor activity is necessary for regulatory gene
expression in the primitive streak
Components of numerous pathways require FGFR activ-
ity for expression. Expression of the receptors PDGFRA,
EPHA1,a n dNOTCH1 (Figure 3A-B, E-F, I-J), and the
ligands DLL1, WNT5B, WNT8A,a n dFGF4 (Figure 3M-
N, Q-R, U-V, Y-Z), were significantly reduced in
embryos exposed to SU5402. Surprisingly, FGF8 mRNA
levels were unchanged or slightly elevated by SU5402
treatment (Figure 3O’-P’). The T-box transcription fac-
tor T was downregulated in the primitive streak but not
in Hensen’s node or the notochord, (Figure 3C’-D’),
while expression of TBX6 was globally downregulated
by SU5402 treatment (Figure 3G’-H’). Whereas SNAI2
was expressed in the preingression epiblast, primitive
streak, and mesoderm in control embryos (Figure 3K’-
k”), SU5402 treatment inhibited SNAI2 expression only
in the preingression epiblast (Figure 3L’-l”).
The SNAIL transcription factors are widely regarded
as key regulators of EMT through their ability to down-
regulate E-cadherin in epithelial cells [29]. In mice,
embryos lacking FgfR1 fail to express Snai1 in the primi-
tive streak, leading to the persistence of E-cadherin
expression and failure of cells to exit the epiblast and
migrate through the primitive streak [27]. Since SU5402
abrogates SNAI2 expression only in the preingression
epiblast (Figure 3K’-l”), we investigated the effects of
SU5402 treatment on E-cadherin mRNA and protein
levels and localization. In control embryos, E-cadherin
protein was localized primarily to the periphery of all
cells in the epiblast, primitive streak, and medial meso-
derm (Figure 4A-A’,A ’”, and 4C; Additional file 1, Fig-
ure S1A-G). E-cadherin labelling in ventral streak cells
remained high, while mesodermal cells near the streak
showed slightly reduced E-cadherin staining intensity
that remained primarily localized to the cell periphery
(Figure 4C). In posterior regions of control embryos, E-
cadherin labelling was observed throughout the meso-
derm layer, while in more anterior regions, E-cadherin
levels were reduced in the lateral mesoderm (Additional
file 1, Figure S1A-G). Surprisingly, in cells of SU5402
treated embryos, neither the levels nor the localization
of E-cadherin protein appeared different from controls
(compare Figure 4A’ and 4C with Figure 4B’ and 4D;
Additional file 1, Figure S1).
Although E-cadherin labelling patterns were indistin-
guishable between control and SU5402 treated embryos
(compare Figure 4A’ and 4C with Figure 4B’ and 4D;
Additional file 1, Figure S1), striking differences in epi-
blast cell morphology were apparent between the groups.
Cells in the preingression epiblast of control embryos
exhibited the typical, highly polarized epithelial morphol-
ogy (Figure 4A’ and 4C). However, in the posterior half
of SU5402 treated embryos, cells in the preingression
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Page 4 of 17Figure 2 Inhibition of FGFR activity blocks cell migration from the epiblast through the primitive streak to the mesoderm.A - B :
Combined brightfield and fluorescence images of control (A) or SU5402 treated (B) embryos. Embryos were treated for two hours with DMSO
carrier or SU5402, and then electroporated with a GFP expression construct. A’-A": indicates transverse sections through the control embryo in A;
B’-B": represents transverse sections through the embryo shown in B. C: Quantification of GFP-expressing cell location at 5 hours after
electroporation. EPIBLAST includes preingression epiblast and lateral epiblast extending to the area pellucida-opaca border; STREAK includes the
primitive streak; MESODERM includes the medial and lateral mesoderm regions to the area pellucida-opaca border (see Figure 1A for depiction
of domains). Migration of cells to the mesoderm is essentially abolished in SU5402 treated embryos. Abbreviations: PS, primitive streak; EP,
epiblast; MS, mesoderm; EN, endoderm.
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Page 5 of 17Figure 3 Effects of SU5402, the MEK inhibitor U0126, and the PI3K inhibitor LY294002 on gene expression in the primitive streak
region. A-P’: Whole mount images showing mRNA expression in control (DMSO), SU5402, U0126 and LY294002 treated embryos. Arrows in C’-D’
point to Hensen’s node. Brackets in k"-l” indicate the preingression epiblast. Q’: Western blot analysis comparing total versus phosphorylated
ERK1/2 (p-ERK) and AKT (p-AKT) in the preingression epiblast and primitive streak of DMSO versus SU5402, U0126 and LY294002 treated
embryos.
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Page 6 of 17Figure 4 E- and N-cadherin expression in control and SU5402 treated embryos. A-B: Brightfield images of control (A) and SU5402 treated
(B) embryos that were processed for immunofluorescence analysis of E-cadherin (ECad) and N-cadherin (NCad). A’-A’": transverse section
showing the same microscopic field at the indicate streak level of the control embryo in A, visualizing E-cadherin protein (A’), N-cadherin protein
(A”), and E-cadherin plus N-cadherin (A’”). B’-B’": transverse section showing the same microscopic field at the indicate streak level of the SU5402
treated embryo in B, visualizing E-cadherin protein (B’), N-cadherin protein (B”), and E-cadherin plus N-cadherin (B’”). C-D: higher magnification
views of the boxed areas in A’ and B’. E-H: Whole mount ISH visualization of N-cadherin (E, F) and E-cadherin (G, H) mRNAs in control and
SU5402 treated embryos. I: Realtime RT-PCR analysis showing relative E-cadherin and EPHA1 mRNA levels in control versus SU5402 treated
primitive streak region (preingression epiblast, primitive streak, medial mesoderm) and isolated preingression epiblast. Error bars indicate standard
deviation. Abbreviations: Mes, mesoderm; End, endoderm.
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morphology seen in normal preingression epiblast cells
(compare Figure 4A’ and 4C with 4B’ and 4D).
In control embryos, N-cadherin protein was detected
in all cells of the mesoderm and endoderm layers (Fig-
ure 4A”; Additional file 1, Figure S1A-G; [23]).
In posterior regions of control embryos, N-cadherin
was absent from dorsal primitive streak cells, while in
more anterior regions staining was evident in some
cells of the dorsal primitive streak (Additional file 1,
Figure S1A-G). The relative proportions of N- and
E-cadherin labelling varied between individual cells of
the streak and the mesoderm layer (Figure 4A’”). In
contrast to E-cadherin, N-cadherin labelling intensity
was significantly reduced in the posterior mesoderm of
SU5402 treated embryos compared with control
embryos (contrast Figure 4B” with Figure 4A”). In
agreement with this, ISH analysis showed a significant
reduction of N-cadherin mRNA in the posterior primi-
tive streak region of SU5402 treated embryos (Figure
4E-F). In more anterior regions, however, N-cadherin
staining appeared roughly equivalent in control
and SU5402 treated embryos (Additional file 1, Figure
S1). N-cadherin labelling intensity was also roughly
equivalent in the endoderm of control versus treated
embryos (Figure 4A” versus 4B”; Additional file 1,
Figure S1).
FGFR inhibition leads to SNAI2 downregulation in the
preingression epiblast, but not in the middle to lower
portions of the streak or in mesoderm cells (Figure 3K’-
l”). Since SNAI2 is known to repress E-cadherin gene
transcription, E-cadherin mRNA levels were also
assessed by ISH and PCR analyses. By ISH, E-cadherin
mRNA levels in control and SU5402 treated embryos
appeared no different in the preingression epiblast or in
other regions of the embryo (Figure 4G-H). By RT-PCR,
E-cadherin mRNA levels were not statistically different
in primitive streak or in preingression epiblast regions
of control versus treated embryos (Figure 4I), though
mRNA levels in the isolated preingression epiblast of
SU5402 treated embryos showed a trend towards being
reduced (p = 0.053). E-cadherin mRNA levels in the
mesoderm were low but detectable in both control and
treated embryos (approximately eight-fold lower than in
the epiblast; data not shown). Altogether, the immuno-
fluorescence, ISH and RT-PCR analyses fail to show an
increase in E-cadherin levels following inhibition of
FGFR activity, despite a reduction of SNAI2 mRNA in
the preingression epiblast.
To further explore the relationship between SNAI2
and E-cadherin expression, the effect of SNAIL over
expression on E-cadherin protein levels and localization
was investigated. Three FLAG-tagged SNAIL expression
vectors were utilized: wild-type chicken SNAI2
(WTcSNAI2), wild-type human SNAI1 (WThSNAI1;
SNAI1 is expressed in the mammalian primitive streak),
and a degradation resistant form of human SNAI1
(6SAhSNAI1) that shows an enhanced ability to down-
regulate E-cadherin and induce EMT [37].
The epiblast and primitive streak of stage 3d embryos
was electroporated with one of the SNAIL expression
vectors (or a GFP expression plasmid as a control), then
incubated for 8 hours. Following fixation, embryos were
assayed by dual immunofluorescence with antibodies to
FLAG or GFP, and to E-cadherin. Regardless of the
SNAIL construct used, over expression did not alter
E-cadherin protein levels or localization (Figure 5).
SNAIL-positive cells were scattered throughout the epi-
blast, primitive streak and mesoderm in distributions
that were not different from control embryos electropo-
rated with a GFP expression plasmid (Figure 5A-D).
Regardless of the SNAIL construct electroporated, over
expression did not apparently cause epiblast cells to
undergo precocious EMT, since many SNAIL-positive
cells were observed in the epiblast and in the primitive
streak. Importantly, none of the SNAIL constructs
appeared to downregulate E-cadherin protein, as
SNAIL-expressing cells retained E-cadherin protein at
their periphery in patterns indistinguishable from non-
expressing cells or cells of embryos expressing GFP
(compare Figure 5B’-D” with 5A’-A”). The ability of
SNAIL expression constructs to downregulate E-cad-
herin was confirmed by transfection into MDCK cells
(not shown). These results indicate that, within the
time-course of the experiment, SNAIL over expression
is insufficient to downregulate E-cadherin protein levels.
FGF signalling during gastrulation is propagated via RAS/
MAPK and PI3K/ATK pathways
FGF signalling can activate a number of downstream
signalling cascades, including Ras to mitogen-activated
protein kinase (RAS/MAPK) and phosphatidylinositol 3-
kinase (PI3K/AKT) [38]. To determine if SU5402 affects
either of these pathways, the phosphorylation states of
ERK1/2 and AKT were assayed in the preingression epi-
blast and primitive streak regions of control versus
SU5402 treated embryos. Compared with DMSO treated
control embryos, SU5402 treatment markedly reduced the
phosphorylation levels of ERK and AKT (Figure 3Q’).
To determine the contribution of the RAS/MAPK and
PI3K/AKT activity to gene expression in the primitive
streak region, embryos were treated with the MEK inhi-
bitor U0126 or the AKT inhibitor LY294002, and
assayed for expression of candidate genes. Consistent
with results obtained using SU5402, inhibition of MEK
activity resulted in downregulation of the signalling
pathway receptors PDGFRA, EPHA1,a n dNOTCH1
(Figure 3C, G, K), ligands DLL1, WNT5B,a n dWNT8A
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Page 8 of 17(Figure 3O, S, W), and the transcription factor T
(Figure 3D’). In contrast, FGF4 and TBX6 transcript
levels were unaffected by U0126 (Figure 3A’,I ’). As
observed following SU5402 treatment, U0126 abolished
SNAI2 expression only in the preingression epiblast
while expression in the primitive streak and mesoderm
was unaffected (Figure 3M’,m ”). Western blot analysis
showed that U0126 reduced the levels of phosphory-
lated ERK, while levels of phosphorylated AKT were
unchanged (Figure 3Q’).
The expression of most FGFR and MEK-dependent
genes was unaffected by AKT inhibition (Figure 3D, L,
P, X, F’). However, EPHA1, which was abolished by both
SU5402 and U0126 treatments (Figure 3F-G), and
SNAI2, which was inhibited only in the preingression
epiblast region (Figure 3L’-m”), were also downregulated
by LY294002 (Figure 3H, N’,n ”). FGF4 and TBX6 tran-
script levels were unaffected by U0126 treatment (Figure
3A’,I ’), but were essentially abolished by treatment with
LY294002 (Figure 3B’,J ’). Western blot analysis demon-
strated that LY294002 treatment greatly reduced phos-
phorylated AKT levels while levels of phosphorylated
ERK were unchanged (Figure 3Q’). Together, these
results suggest that FGF signalling acts through both
ERK and AKT to control regulatory gene expression in
the preingression epiblast and primitive streak. Most
FGFR dependent genes assayed required only ERK sig-
nalling for high-level expression, while expression of a
few genes was dependent on signalling only through
AKT. EPHA1 expression and SNAI2 expression in the
preingression epiblast were dependent on both signalling
pathways.
Microarray analysis of gene expression
Considering the specific effects of FGFR, MEK, and AKT
inhibition on SNAI2 expression in the preingression epi-
blast, microarray studies were performed to obtain a
more comprehensive view of gene expression changes in
the different epiblast expression domains illustrated in
Figure 1A. First, gene expression levels were compared
between lateral and preingression epiblast, excluding the
primitive streak. Approximately 630 genes were upregu-
lated in the preingression epiblast versus lateral epiblast
(Table 1; Additional file 2, Table S1; adjusted p < 0.05, at
least 1.5 fold change; see methods for discussion of data
analysis). Genes upregulated in the preingression epiblast
Figure 5 SNAIL over expression does not alter E-cadherin protein. Confocal microscopy images of transverse sections of embryos
electroporated with a GFP expression vector (A-A”), or FLAG-tagged versions of wild type chicken SNAI2 (WTcSNAI2; B-B”), wild type human
SNAI1 (WThSNAI1; C-C”), or a degradation resistant form of human SNAI1 (6SAhSNAI1; D-D”). GFP (A) or FLAG (B-D) (green) and E-cadherin (red)
were visualized by indirect immunofluorescence and confocal microscopy.
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Page 9 of 17Table 1 Summary of Changes in Regulatory Gene Expression
Gene Name Reference
Sequence
Preingression Vs.
Lateral Epiblast
Preingression
Epiblast + SU5402
(FGFR)
Preingression
Epiblast + U0126
(MAPK)
Preingression
Epiblast + LY294002
(PI3K)
T T, brachyury homolog NM_204940 U
1,3 D
1,2,3 D
1,2,3 NC
1,2,3
TBX4 T-box 4 NM_001030537 NC
1 D
1 NC
1 D
1
TBX6 T-box 6 NM_001030367 U
1,2,3 D
1, 2,3 NC
1,2,3 D
1,2,3
EOMES eomesodermin homolog XM_426003 U
1 D
1,2 D
1 D
1
ETV1 ets variant gene 1 (Er81) NM_204917 U
1,2,3 D
1,2 D
1 NC
1
ETV4 ets variant gene 4 (Pea3) XM_418106 NC
1,2,3 D
1,2,3 D
1,3 NC
1,3
ELK3 ETS-domain protein (SRF
accessory protein 2)
NM_001030749 U
1,3 D
1,2 D
1 NC
1
EVX1 even-skipped homeobox 1 XM_425994.2 NC
1 D
1,2 D
1 D
1
DLX1 distal-less homeobox 1 NM_001045842.2 NC
1 D
1 NC
1 D
1
TLX3 T-cell leukemia homeobox 3 XM_001233188.1 U
1 D
1 ND ND
CDX4 caudal type homeobox 4 NM_204614.1 U
3 D
3 D
3 ND
SNAI2 snail homolog 2 XM_419196.2 U
2,3 D
2,3 D
3 D
3
ZIC3 Zic family member 3 AF188736 NC
1 D
1 D
1 NC
1
JAZF1 JAZF zinc finger 1 XM_418732.2 NC
1 D
1 NC
1 D
1
XBP1 X-box binding protein 1 NM_001006192.1 U
1 D
1 D
1 D
1
ATF3 activating transcription
factor 3
XM_419429.2 U
1 D
1 D
1 NC
1
ATF4 activating transcription
factor 4
NM_204880.1 U
1 D
1 D
1 D
1
POU3F1 POU domain, class 3,
transcription factor 1 (Oct 6)
XM_427826.1 NC
1,3 D
1 D
1 D
1
HDAC7A histone deacetylase 7A NM_001031402.1 NC
1 D
1 NC
1 D
1
HDAC8 histone deacetylase 8 XM_420178.2 NC
1 D
1 D
1 D
1
FGF3 fibroblast growth factor 3 NM_205327.1 U
1, D
1 D
1 NC
1
FGF4 fibroblast growth factor 4 NM_001031546.1 U
1,2,3 D
1,2,3 NC
1,3 D
3
FGF8 fibroblast growth factor 8 NM_001012767.1 U
1,3 NC
1,2,3 NC/U
1,3 NC
1,3
FGF18 fibroblast growth factor 18 NM_204714.1 U
1 D
1 D
1 NC
1
SPRY1 sprouty homolog 1,
antagonist of FGF signalling
NM_001097524 U
1,2,3 D
1,2,3 D
1,3 NC
1,3
SPRY2 sprouty homolog 2 NM_204800.1 U
1,3 D
1,3 D
1 D
1
SPRY3 sprouty homolog 3 U
1 ND D
1 NC
1
SPRED2 sprouty-related, EVH1
domain containing 2
XM_419341.2 U
1 D
1 D
1 NC
1
DUSP6 dual specificity
phosphatase 6
NM_204354 U
1,3 D
1 D
1 NC
1
IL17RD interleukin 17 receptor D
(SEF)
NM_204515.1 NC
1 D
1 D
1 NC
1
WNT3 wingless-type MMTV
integration site family, member 3
NM_204675 U
1,3 NC
1 NC
1 NC
1
WNT8A wingless-type MMTV
integration site family, member 8A
NM_205531.1 U
1,2,3 D
1,2,3 D
1,2,3 D
1,2,3
WNT5B wingless-type MMTV
integration site family, member 5B
NM_001037269.1 U
1,2,3 D
1,2,3 D
1,3 NC
1,3
FZD7 frizzled homolog 7 NM_204221.1 U
1,3 D
1 NC
1 NC
1
LOC417741 similar to secreted
Xwnt8 inhibitor sizzled
NM_204675 NC
1 D
1 D
1 D
1
NOTCH1 Notch homolog 1,
translocation-associated
XM_415420 U
1,2,3 D
1,2,3 D
1,2,3 NC
1,2,3
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including NOTCH1, DLL1, WNT3A, WNT5B, WNT8A,
EDNRB, EDNRB2, PDGFRA, FGF3, FGF4, FGF8, FGF18,
and EPHA1. Also upregulated were numerous modula-
tors of FGF signalling, including SPRY1, SPRY2, SPRED1,
SPRED 2,a n dDUSP6. Upregulated transcription factor
genes included the T-Box genes T, TBX4, TBX6 and
EOMES,t h eE T Sf a c t o r sETV1, ETV4 and ELK3, several
homeobox-containing genes such as DLX1 and MKX,a s
well as SNAI2, ZIC3, ATF3, ATF4, XBP1,a n dPOU3F1
(OCT6).
A second series of microarray studies were performed
to extend the ISH studies above in identifying changes
in gene expression in preingression epiblast (excluding
the primitive streak) of control embryos versus embryos
treated with SU5402, U0126, or LY294002 (Table 1;
Additional files 3, 4, 5, Tables S2-S4). Pairwise compari-
sons of mRNA levels in preingression epiblast from con-
trol versus treated embryos showed that expression
levels of more than 500 genes were downregulated in
the preingression epiblast following inhibition of FGFR
kinase activity by SU5402 treatment (Additional file 3,
Table S2). Using gene ontology terms to identify regula-
tory molecules, FGF signalling was found to regulate
numerous ligands, receptors and pathway modulators of
several signalling pathways (Table 1; Figure 6). Of the
five FGF ligands expressed in the primitive streak and
preingression epiblast, four (FGF3, FGF4, FGF18 and
FGF19) were downregulated by SU5402 treatment while
FGF8 was expressed at control levels. Expression of core
components of the FGF signalling pathway was generally
unaffected, while numerous positive and negative FGF
signalling modulators were downregulated. Members of
both the canonical and non-canonical WNT pathways
were also downregulated, as were numerous negative
regulators of WNT signalling (Figure 6). Expression of
RHOA and JNK was also dependent on FGFR activity.
Consistent with ISH results presented above, the
NOTCH1 receptor and DLL1 ligand were highly down-
regulated, as were the NOTCH pathway transcriptional
co repressor CTBP and the co activator SNW1. Addi-
tional signalling pathway genes downregulated by FGFR
inhibition included EDNRB, EDNRB2, PDGFRA,a n d
EPHA1. Further confirmation of these results was
obtained by realtime RT-PCR analysis (Table 1; Addi-
tional file 6, Figure S2).
Comparison of expression changes in the preingression
epiblast obtained with SU5402, U0126, and LY294002
revealed several patterns of gene regulation (Table 1;
Additional files 3, 4, 5, Tables S2-S4). Most but not all
of the genes downregulated by SU5402 were also down-
regulated by U0126. This included all identified FGF
pathway members except for FGF4 which was unaf-
fected by U0126, and FGF8 and FGFR1 which were
unaffected by either inhibitor. Expression of the three
ETS factors ETV1, ETV4 and ELK3 was also dependent
on MAPK signalling. Expression of some transcription
factors within the same family showed a differential
response to the two inhibitors. For example, within the
T-box transcription factor family, T and EOMES were
highly downregulated by U0126 treatment, while TBX4
and TBX6 transcript levels were not affected. Similarly,
the homeobox containing genes DLX1 and MKX were
unaffected by U0126 despite being downregulated by
SU5402. In fact, expression of TBX4, TBX6, DLX1,a n d
MKX required PI3K signalling, while being independent
of the MAPK pathway. A few genes required signalling
through both pathways for expression (for example
EPHA1, EVX1, SPRY2, SZL, and the preingression epi-
blast expression of SNAI2).
Table 1 Summary of Changes in Regulatory Gene Expression (Continued)
DLL1 delta-like 1 NM_204973.1 U
1,2,3 D
1,2,,3 D
1,3 NC
1,3
SNW1 SNW domain containing 1 BX931222 U
1 D
1 NC
1 D
1
NET1 neuroepithelial cell
transforming gene 1
NM_001030648.1 NC
1 D
1 D
1 D
1
CER1 cerberus 1, cysteine knot
superfamily, homolog
NM_204823.1 U
1,3 D
1 U
1 D
1
CFC1 cripto, FRL-1, cryptic family 1 NM_204700.1 U
1 D
1 D
1 NC
1
EPHA1 EPH receptor A1 NM_204360.1 U
1,2,3 D
1,2,3 D
1,3 D
1,3
EDNRB endothelin receptor type B XM_417001.2 U
1 D
1,2 D
1 D
1
EDNRB2 endothelin receptor B
subtype 2
NM_204120.1 U
1,3 D
1,3 D
1 NC
1
PDGFRA platelet-derived growth
factor receptor, alpha polypeptide
NM_204749.1 U
1,3 D
1,3 D
3 NC
3
ROR1 receptor tyrosine kinase-like
orphan receptor 1
NM_204509.1 U
1 D
1 D
1 D
1
U: Gene Expression Increased. D: Gene Expressed Reduced. NC: No Change. ND: Not determined.
Superscripts: Result Confirmed by: 1. Microarray; 2. PCR; 3. In Situ Hybridization.
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The role of FGF signalling in regulating gastrulation has
been investigated in several classes of organisms. In
frogs, FGF ligands can induce mesoderm in animal cap
assays, and FGFR function and downstream pathway
activity is required for mesoderm formation [39-41].
FGFs can induce mesoderm in chicken epiblast [25,26],
and inhibition of FGF signalling blocks appearance of
the primitive streak [6]. In mice, FgfR1 null embryos
form a primitive streak, however primitive streak cells
fail to express Snai1, to downregulate E-cadherin, or to
undergo EMT [31].
In the present study, we find that blocking FGFR
activity during gastrulation in chicken embryos also
inhibits cell migration through the primitive streak.
However, E-cadherin expression is not increased in
SU5402 treated embryos, even in the preingression epi-
blast where SNAI2 expression is reduced. Although
loss of E-cadherin is a primary requirement for EMT in
numerous contexts, immunofluoresence analyses
presented here and by others [23] show that EMT dur-
ing avian gastrulation is not temporally linked with
downregulation or altered intracellular localization of
E-cadherin protein. EMT during gastrulation is closely
associated with upregulation of N-cadherin in emerging
mesoderm and endoderm cells, while E-cadherin protein
levels decline only gradually as cells move to lateral
regions of the embryo. E-cadherin levels also gradually
decline in the presomitic mesoderm. Over expression of
three different SNAIL proteins also failed to alter
E-cadherin protein levels or localization in epiblast, pri-
mitive streak, or mesoderm cells. These findings do not
rule out more subtle changes in E-cadherin function in
the primitive streak unrelated to protein expression
levels or localization detectable by confocal microscopy.
The temporally controlled pharmacological approach
u s e di nt h i ss t u d ym a yn o tb ed i r e c t l yc o m p a r a b l et o
the FGFR gene ablation studies reported in mice [27].
Figure 6 Changes in mRNA levels among various signalling pathway members following inhibition of FGFR activity.R e p r e s e n t a t i v e
aspects of each pathway are presented to illustrate FGFR dependent changes in gene expression. Genes shown in green require FGF signalling
for expression. Genes shown in gray are expressed in the primitive streak but expression is not dependent on FGF signalling. Red are genes
upregulated following FGF signalling inhibition.
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ences between chickens and mice in the regulatory
pathways downstream of FGF signalling controlling the
movement of cells through the primitive streak. Evi-
dence presented here suggests that FGF-dependent
pathways controlling EMT are independent of changes
in E-cadherin expression, and furthermore that loss of
E-cadherin is not temporally associated with EMT.
How, then, is FGF signalling regulating the movement
of cells through the chicken embryo primitive streak?
The broad requirement of FGF signalling for expression
of components of numerous regulatory pathways during
avian gastrulation suggests that FGF signalling may co-
ordinately control multiple pathways related to the EMT
process. RHOA regulation of microtubule dynamics is
required to regulate basement membrane breakdown
and EMT during avian gastrulation [23], and non-
canonical WNT signalling is necessary for cells to tran-
sition from epiblast through the primitive streak to
the mesoderm [16]. While direct regulation of these
pathways by FGF signalling has not been addressed,
expression of pathway components (RHOA and NET1;
non-canonical WNT5B) is regulated by FGFR activity
(Figure 6; Table 1; Additional file 3, Table S1; Addi-
tional file 6, Figure S2). Expression of the EPHA recep-
tor, EPHA1, in preingression epiblast and primitive
streak is also dependent on FGF signalling. Preliminary
studies indicate that its function is also necessary for
cells to undergo gastrulation (K.M. Hardy, P.B. Antin,
unpublished observations). N-cadherin expression is also
dependent on FGFR activity. Recent findings have
shown that N-cadherin expression is required for cells
to properly migrate away from the primitive streak [18].
The intracellular FGF signalling antagonists SPROUTYs
and SPREDs contribute to the coordinate regulation of
mesoderm induction and cell movement by differentially
regulating signalling downstream of the FGF receptor-
ligand interaction. SPROUTYs antagonize PLCg signal-
ling to regulate convergent extension, while SPREDs
regulate the RAS/MAPK pathway to modulate gene
expression [42]. In the chicken preingression epiblast,
FGFR/RAS/MAPK signalling regulates expression of
SPROUTY1, SPROUTY2, SPROUTY3, and SPRED2,s u g -
gesting that both pathways are activated. Although roles
for NOTCH, ENDOTHELIN and canonical WNT path-
ways in regulating EMT during avian gastrulation have
not yet been delineated, major components of each
pathway are regulated by FGF signalling and each has
been shown to regulate aspects of EMT in other con-
texts [43,44].
It is intriguing that all FGF ligands examined except
FGF8 are downregulated following inhibition of FGF sig-
nalling. Mechanisms regulating its expression are not
known. Several laboratories have shown that FGF8 is
required for mesoderm cells to migrate away from the
primitive streak, but not for EMT. Mouse embryos lack-
ing FGF8 (which also fail to express FGF4 in the primi-
tive streak) show normal EMT within the primitive
streak, however mesodermal cells fail to migrate away
from the midline [32]. It is possible that both ligands
regulate the migration of mesoderm cells, because, in
chicken, the lateral migration of mesoderm cells is
directed towards a source of FGF4 but away from FGF8
[21]. How cells achieve this directional migration is
unclear. Emerging mesoderm cells downregulate FGF
receptor expression (Figure 1; [17,20]), although they
become re-expressed as cells move to more lateral
regions.
FGFR activity in the preingression epiblast controls
both the RAS/MAPK and PI3K/AKT pathways. Some
genes are regulated only through one pathway, while a
few genes require both pathways for expression. For
example, T expression is mediated through RAS/MAPK
but is independent of PI3K/AKT signalling, while the
related T-Box factors TBX4 and TBX6 require PI3K/
AKT signalling but are independent of the RAS/MAPK
pathway. The T-Box factor EOMES requires both path-
ways for expression. The regulation of SNAI2 expression
by FGFR signalling is particularly interesting. Following
inhibition of FGFR kinase activity (or inhibition of MEK
or AKT activity), SNAI2 expression is downregulated in
the preingression epiblast but not in the primitive streak
or mesoderm. This finding supports the concept of
modular regulation of gene expression in the primitive
streak region (Figure 1), and also highlights species-
specific differences in the regulation of SNAIL genes.
Collectively, the FGFR inhibitor SU5402, the MEK
inhibitor U0126, and PI3K inhibitor LY294002 have
been used in a large number of published studies to
investigate FGF signalling pathways. However, in some
contexts, each can inhibit other pathways, and multiple
signalling pathways can signal through MEK and/or
PI3K. SU5402, for example, can also inhibit the activity
of VEGFR2. In this study, it is highly unlikely that
VEGF signalling rather than FGF signalling is regulating
the pathways shown to be affected by SU5402, because
VEGFR2 is not expressed in the avian primitive streak
and the VEGFR inhibitors SU1498 and SU5406 fail to
reduce expression of TBX6 or T in the primitive streak
(data not shown). Since MEK and AKT can act down-
stream of pathways other than FGF signalling, we have
limited our comparisons of genes regulated by U0126
and LY294002 to those that are also regulated by
SU5402.
Although in this study we have focused on genes that
are positively regulated by FGF signalling, the preingres-
sion epiblast-specific downregulation of SNAI2 indicates
that another likely function of FGF signalling is to
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to preingression epiblast. At least 600 genes are downre-
gulated in the preingression epiblast versus lateral epi-
blast, and at least 300 of these genes are upregulated
following SU5402 treatment. SNAI2, and perhaps other
transcriptional repressors, might also function to repress
the transcription of genes that would preclude transition
from epiblast to mesoderm and endoderm. These tran-
scription factors may also repress genes that are upregu-
lated by gastrulation signals but whose precocious
expression prior to entering the streak would be detri-
mental. While additional studies will be required to
identify the underlying biological significance, FGF sig-
nalling in the preingression epiblast both activates and
represses gene expression.
Conclusions
We have shown that FGF signalling is required for the
movement of cells from the epiblast through the primitive
streak to the mesoderm of gastrula stage chicken embryos.
FGF dependent mechanisms regulating migration are
independent of apparent alterations in E-cadherin protein
expression or localization. Further, the levels and intracel-
lular localization of E-cadherin do not appear to change as
cells undergo EMT during gastrulation. FGF signalling
positively and negatively regulates the expression of a
large number of genes in the preingression epiblast, primi-
tive streak and newly formed mesoderm layer (Figure 6;
Table 1). These include members of several major signal-
ling pathways, among them the FGF, canonical and non-
canonical WNT, NOTCH, PDGF, EPH-EPHRIN, and
ENDOTHELIN pathways. A large number of transcrip-
tional regulatory factors are also regulated by FGFR activ-
ity, and well as the cell adhesion molecule, N-cadherin.
Of pathways known to regulate cell migration through
the primitive streak, FGF signalling regulates the expres-
sion of components of several, including RHOA and non-
canonical WNT5B.
Methods
Embryo culture and pharmacological treatments
Fertile chicken (Gallus gallus) eggs were obtained from
Hy-Line International (Spencer, IA) incubated 37°C in a
humid environment until Hamburger-Hamilton (HH)
stage 3d-4 [45,46]. Embryos were removed from the egg
and cultured in modified New culture on egg agar plates
[47]. Embryos were submerged in 100 μM SU5402 (Pfi-
zer, New York, NY), 100 μM U0126 (Promega, Madison,
WI), 100 μM LY294002 (Invivogen, San Diego, CA) or
DMSO carrier diluted in cell culture medium supple-
mented with penicillin, streptomycin and glutamate
(Invitrogen). Incubation of embryos younger than stage
3d-4 in the inhibitors led to highly impaired develop-
ment, and so only stage 3d-4 embryos were used for
these studies. Embryos were incubated for 5 hours in a
cell culture incubator at 37°C, and then were either
fixed in 4% paraformaldehyde in PBS (PFA) and pro-
cessed for ISH, or microdissected into an NP-40 extrac-
tion buffer and processed for western blot analysis. In
GFP cell migration studies, stage 3d embryos were pre-
treated with SU5402 or DMSO for 2 hours prior to
electroporation, and then were reincubated in SU5402
or DMSO for a further 5 hours before fixation.
Whole-mount in situ hybridization and PCR
E m b r y o sa tt h ed e s i r e ds t a g ew e r ee i t h e rd i r e c t l yf i x e d
in 4% PFA overnight at 4°C, or were subjected to treat-
ment conditions and then fixed. Embryos were prepared
for hybridization essentially according to Nieto et al.
[48], but with minor modifications. Digoxigenin-labelled
RNA probes were generated with the following lineariz-
ing restriction enzymes (Invitrogen, Carlsbad, CA) and
RNA polymerases (Roche, Indianapolis, IN): T (R. Run-
yan, University of Arizona), HindIII/T3; DLL1 (BBSRC),
Not1/T3; EPHA1 [13], EcoR1/T7; EFNB2 [13], EcoR1/
T7; FGF4, FGF8 (G. Schoenwolf, University of Utah),
EcoR1/T7; FGFR1, FGFR2, FGFR3 (K. Storey, University
of Dundee), Xho1/T3; NOTCH1 (BBSRC), Not1/T3;
PDGFRA (BBSRC), Not1/T3; SNAI2 (University of Dela-
ware), Not1/T3; TBX6, Xba1/T7; WNT5B (S. Chapman,
Clemson University), EcoR1/T3; WNT8A (K. Yutzey,
Cincinnati Children’s Medical Center), Sph1/SP6.
Embryo cell layers were isolated from control and
treated embryos using electrolytically sharpened tung-
sten needles, then placed in TRIZOL reagent (Invitro-
gen) and total RNA isolated. RNA concentrations were
determined using a Nanodrop, and RNA was stored in
DEPC treated H20 at -80°C for up to three months.
cDNA was transcribed using the iScript cDNA synthesis
kit (Bio-Rad, Richmond, CA). Intron spanning PCR pri-
mers were designed using MacVector software. Acces-
sion numbers of the mRNA sequences used for primer
design, primer sequences, and PCR product lengths are
provided in Additional file 7, Table S5. Realtime PCR
assays were performed in triplicate, including no tem-
plate controls, in a Rotorgene Q PCR machine using
standard protocols and the Rotorgene statistical analysis
software. PCR products were sequenced to confirm
identity. Following assessment of several candidate refer-
ence genes, hydroxymethylbilane synthase (HMBS) was
chosen because HMBS mRNA levels were unchanged
between control and experimental samples.
Antibodies and western blots
Rabbit anti-GFP (Invitrogen) and rabbit anti-FLAG (Cell
Signalling, Danvers, MA) were used at 1:500 for immu-
nofluorescence. Mouse anti-E-cadherin (Cat. No.
610181; BD Biosciences, San Jose, CA) and mouse anti-
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at 1:500 and 1:250 respectively for immunofluorescence.
The mouse monoclonal antibody against E-cadherin was
generated using the C-terminal 148 amino acids of
human E-cadherin as the immunogen. This antibody
recognizes a single band of 120 kD on western blots of
whole cell embryo lysates (data not shown), and has
been used in other studies showing E-cadherin expres-
sion during chicken gastrulation [23]. Rabbit anti-pERK
(phospho-p44/42), rabbit anti-ERK (p44/42), rabbit anti-
pAKT, and rabbit anti-AKT (all Cell Signalling) were
used at 1:1000 for western blotting. Goat anti-rabbit-
AF488, goat anti-mouse-IgG1-AF594 and goat anti-
mouse-IgG2a-AF488 (all Invitrogen) were used at 1:500
for immunofluorescence. Donkey anti-rabbit-HRP (Jack-
son ImmunoResearch, West Grove, PA) was utilized at
1:500 for immunohistochemistry and 1:7500 for western
blotting.
For western blots, embryos treated with pharmacologi-
cal inhibitors were washed with PBS, then endoderm
and mesoderm was removed carefully removed with a
sharpened tungsten needle. The primitive streak and
preingression epiblast region from both sides of the pri-
mitive streak (epiblast directly adjacent to the primitive
streak and extending the full length of the primitive
streak excluding Hensen’sn o d e )w a si s o l a t e df r o m
12-14 control or treated embryos. Tissue was lysed in
an NP-40 extraction buffer [49], and then proteins were
separated on 7.5% SDS-PAGE gels and transferred to
nitrocellulose membranes. Transfers were verified with
PonceauS staining. Membranes were blocked and
probed using standard protocols. Following protein
detection, antibody conjugates were removed using
Restore western blot stripping buffer (Thermo/Pierce,
Rockford, IL), and verified by repeating secondary anti-
body and subsequent steps. Stripped membranes were
then reprobed for either total ERK or AKT as a control.
Electroporation, constructs, immunofluorescence, and cell
analyses
Electroporation and subsequent immunofluorescence was
carried out essentially as previously described utilizing
the following conditions on an Intracel TSS20 Ovodyne
electroporator: three 400ms pulses at 4V spaced 1s apart.
Briefly, stage 3d embryos were electroporated by targeting
the posterior epiblast. Under these conditions, only epi-
blast cells are electroporated [16]. pBE-WTcSNAI2 was
created by cloning full-length chicken SNAI2 in place of
G F Pi nt h ep B Ev e c t o r .p B E - W T h S N A I 1a n dp B E -
6SAhSNAI1 were subcloned from the CMV-Tag2B vec-
tor (a gift of Dr. MC Hung, University of Texas MD
Anderson Cancer Center, Houston, TX) into the pBE
plasmid in place of GFP. All three of these sequences are
flanked with a C-terminal FLAG tag for detection by
immunofluorescence. Embryos in New culture were
either: 1) electroporated with the pBE plasmid (GFP) or
with pBE-WTcSNAI2, pBE-WThSNAI1 or pBE-6SAhS-
NAI1, and incubated in a cell culture incubator for
8 hours; or 2) pretreated for 2 hours with DMSO or
SU5402, electroporated with the pBE plasmid and then
reincubated for 5 hours. Following incubation, embryos
were fixed and processed for immunofluorescence.
Embryos were dehydrated through methanol and stored
o v e r n i g h ta t- 2 0 ° C ,t h e nr e h y d r a t e da n db l o c k e di n5 %
goat serum in PBS-T for 1 hour at room temperature.
Embryos were incubated in primary antibody diluted in
block overnight at 4°C, then washed extensively and incu-
bated in AlexaFluor-conjugated secondary antibody over-
night at 4°C. Following extensive washing, embryos were
imaged in whole mount on a Leica MZ16FA stereomi-
croscope, and then processed into Paraplast for section-
ing at 8 μm. Transverse section images were captured on
a Leica LeitzDMRXE compound microscope or on a
Zeiss Meta510 confocal microscope.
Cell localization in the epiblast, primitive streak, and
mesoderm was analyzed essentially as previously
described [16]. Positive cells in these areas were counted
for a region of ~100 μm from posterior expression, and
results were presented as proportions of positive cells.
EPIBLAST included preingression epiblast and lateral
epiblast extending to the area pellucida-opaca border;
STREAK included the primitive streak; MESODERM
included the medial and lateral mesoderm regions to the
area pellucida-opaca border (see Figure 1A for depiction
of domains). Significant differences were calculated with
the Student’s T-test feature of Microsoft Excel. Standard
deviations were calculated in Microsoft Excel.
Microarray and pathway analyses
For gene expression comparison between lateral and
preingression epiblast, lateral or preingression epiblast
was microdissected from approximately 30 stage 4
embryos using electrolytically sharpened tungsten nee-
dles (see Figure 1A for depiction of domains). Cell layer
fragments were placed in TRIZOL and RNA isolated
according to standard protocols. RNA quantitation and
integrity was determined using an Agilent Bioanalyzer.
For gene expression comparison between control versus
SU5402, U0126 or LY294002 treated embryos, embryo
treatments were performed as described above. Five
hours after treatment initiation, preingression epiblast
was microdissected from 15-30 control or treated
embryos and processed for RNA extraction. cRNA was
extracted, amplified, labelled and hybridized according
to standard protocols using dye swaps. All microarray
studies were performed using a custom 20,477 feature
70-mer long oligo microarray printed in our laboratory.
The probe set was developed by ARK-Genomics (http://
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using chicken ENSEMBL transcripts, and covers much
of the chicken genome. Normalization was performed
according to a custom pipeline written in the R statisti-
cal computing language. Within chip normalization was
performed using the R package OLIN [50]. Following
normalization, false discovery rates were computed, and
those spots demonstrating a location- or intensity-
dependent bias (FDR > 1%) were subsequently masked
from downstream analysis. Standard libraries in the R
BioConductor package were then used to normalize
between chips [50]. Finally, linear models were fit to the
normalized gene expression data using the limma
library, which computes log2 fold-change (logFC), indi-
cating the direction and quantity of the differential gene
expression between the samples, summary statistics
including T- and B-statistics, and the adjusted p-value
that takes into account the false discovery rate [51]. For
each comparison in every study, Q-values were also
computed using the R package qvalue. Pathways shown
in Figure 6 are derived from the KEGG pathway data-
base (http://www.genome.jp/kegg) and the published lit-
erature. Microarray results have been deposited in the
NCBI Gene Expression Omnibus (GEO; accession
#GSE27403)
Additional material
Additional file 1: Figure S1 E-cadherin and N-cadherin
immunolocalization in control and SU5402 treated embryos.
Transverse sections through a control (A-G) and an SU5402 treated (A’-G’)
embryo, showing immunolocalization of E-cadherin (red) and N-cadherin
(green) at different levels along the primitive streak. Section levels are
shown on the corresponding whole embryo images.
Additional file 2: Table S1 List of genes whose expression levels
increase or decrease between the lateral and preingression epiblast
of stage 4 embryos.
Additional file 3: Table S2 List of genes downregulated or
upregulated in the preingression epiblast by SU5402 treatment.
Additional file 4: Table S3 List of genes downregulated or
upregulated in the preingression epiblast by U0126 treatment.
Additional file 5: Table S4 List of genes downregulated or
upregulated in the preingression epiblast by LY294002 treatment.
Additional file 6: Figure S2 Realtime RT-PCR validation of
Microarray and ISH expression analyses. Realtime RT-PCR analyses of
mRNAs levels in control versus SU5402 treated preingression epiblast.
Data are presented as fold change in preingression epiblast mRNA levels
of control versus SU5402 treated embryos. All samples were run in
triplicate; standard deviations are shown. Ratios are compared to the
control mRNA HMBS (hydroxymethylbilane synthase), the levels of which
were not changed between control and SU5402 treated samples.
Additional file 7: Table S5 Primer sequences used for realtime RT-
PCR validation
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